| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/14/2010 | CN101773653A Chinese medicine composition for treating ablepsia and preparation method thereof |
| 07/14/2010 | CN101773595A Herbal tea for clearing liver and improving eyesight |
| 07/14/2010 | CN101773553A Semiaquilegia root extract, preparation method and application thereof |
| 07/14/2010 | CN101773349A Anion multifunctional pillow |
| 07/14/2010 | CN101564493B Chinese medicine preparation and preparation method thereof |
| 07/13/2010 | US7756559 Device for generating a detectable signal based upon antibody/antigen interaction |
| 07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
| 07/13/2010 | US7754768 1-(3-chloro-2-fluorobenzyl)-3-(2-hydroxyethyl)-thiourea; analgesics; gastrointestinal disorders, chronic pain, glaucoma, vision defects; rheumatoid arthritis, spondylitis, gouty arthritis, osteoarthritis, juvenile arthritis; autoimmune diseases: lupus erythematosus |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2429982C Copper chelators for treating ocular inflammation |
| 07/13/2010 | CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/13/2010 | CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases |
| 07/08/2010 | WO2010078393A1 Kinase inhibitors |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 07/08/2010 | WO2010048365A3 Therapeutic peptide bioconjugates |
| 07/08/2010 | WO2010048095A3 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 07/08/2010 | WO2010016042A8 Treatment of retinal degeneration |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100174000 Carrier in the form of oil-in-water emulsion notably intended for ophthalmic or dermocosmetic use |
| 07/08/2010 | US20100173981 Therapeutic compounds |
| 07/08/2010 | US20100173901 Substituted Heterocyclic Compounds |
| 07/08/2010 | US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 07/08/2010 | US20100173876 Oil-based nsaid compositions and methods for making and using same |
| 07/08/2010 | US20100173874 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| 07/08/2010 | US20100173868 Composition and method for healing tissues |
| 07/08/2010 | US20100173866 Apparatus and method for ocular treatment |
| 07/08/2010 | US20100173852 USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES |
| 07/08/2010 | US20100173019 Method of stabilizing human eye tissue by reaction with nitrite and related agents such as nitro compounds |
| 07/08/2010 | US20100173008 Method of treating or alleviating the symptoms of alesion in mammal |
| 07/08/2010 | US20100172927 Vaccines Against Chlamydial Infection |
| 07/08/2010 | US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins |
| 07/08/2010 | US20100172871 Muller Cell Specific Gene Therapy |
| 07/08/2010 | DE102009003942A1 Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges The use of deuterium oxide for treatment of virus-based diseases of the eye |
| 07/08/2010 | CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 07/08/2010 | CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/07/2010 | EP2204187A1 Human flu vaccine containing four influenza peptides |
| 07/07/2010 | EP2203165A2 Ophthalmic formulation containing paracetamol |
| 07/07/2010 | EP2203163A1 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 07/07/2010 | EP2203160A1 Pharmacological adjunctive treatment associated with glaucoma filtration surgery |
| 07/07/2010 | EP2203050A1 Use of r(+)-n-propargyl-1-aminoindan to treat or prevent hearing loss |
| 07/07/2010 | EP1507866B1 Carotene synthase gene and uses therefor |
| 07/07/2010 | EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | CN101772345A A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 07/07/2010 | CN101766792A Chinese herbal composite for deafness treatment and preparation method thereof |
| 07/07/2010 | CN101766695A Point eye mask and preparation method and application thereof |
| 07/07/2010 | CN101766675A Preparation method of silktree albizia bark extract for inhibiting angiogenesis and application |
| 07/07/2010 | CN101766668A Burdock extract and preparation method and application thereof |
| 07/07/2010 | CN101766643A Dendrobii extract and preparation method thereof |
| 07/07/2010 | CN101766628A Ophthalmic bacterial-infection resisting medicine for external use |
| 07/07/2010 | CN101766617A Compound composition of intal and Statins |
| 07/07/2010 | CN101766601A Drop for treating otitis externa mycotica and preparation method thereof |
| 07/07/2010 | CN101015544B Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage |
| 07/06/2010 | US7750023 Quinuclidine derivatives and medicinal compositions containing the same |
| 07/06/2010 | US7749970 Application of an azalide antibiotic such as azithromycin |
| 07/06/2010 | US7749514 Activatable clostridial toxins |
| 07/06/2010 | US7748379 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/06/2010 | CA2460222C Eustachian tube stent |
| 07/06/2010 | CA2446149C Vitamin d analogues |
| 07/06/2010 | CA2415962C Valsartan salts |
| 07/06/2010 | CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 07/06/2010 | CA2359462C Pyrazole compounds and uses thereof |
| 07/01/2010 | WO2010075315A2 Topical formulations of flap inhibitors for administration to an eye |
| 07/01/2010 | WO2010075197A1 Kinase inhibitors |
| 07/01/2010 | WO2010074992A2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 07/01/2010 | WO2010074940A1 Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response |
| 07/01/2010 | WO2010074284A1 Pyrazolopyrimidine compound |
| 07/01/2010 | WO2010073667A1 Ultraviolet rays protective agent |
| 07/01/2010 | WO2010073235A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | WO2010072829A1 Selective histamine h4 receptor antagonists for the treatment of vestibular disorders. |
| 07/01/2010 | WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 07/01/2010 | WO2010072166A1 Preparation method of dihydroindene amide compounds,their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor |
| 07/01/2010 | WO2010045395A3 Curcumin analog compositions and related methods |
| 07/01/2010 | WO2010042843A3 Composition and method for treating dry eye syndrome |
| 07/01/2010 | WO2010016043A8 Treatment of retinal degeneration |
| 07/01/2010 | WO2010000851A3 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/01/2010 | US20100168448 Methods of Preparing Cannabinoids From Plant Material |
| 07/01/2010 | US20100168250 Use of cyclohexanehexol derivatives in the treatment of ocular disease |
| 07/01/2010 | US20100168216 Prostaglandin pharmaceutical compositions |
| 07/01/2010 | US20100168207 Compositions and methods for sirna inhibition of angiogenesis |
| 07/01/2010 | US20100168204 Therapeutic uses of inhibitors of RTP801L |
| 07/01/2010 | US20100168192 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
| 07/01/2010 | US20100168189 Therapeutic substituted lactams |
| 07/01/2010 | US20100168169 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168121 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 07/01/2010 | US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168081 Galantamine as a neuroprotective drug for retinal ganglion cells |
| 07/01/2010 | US20100168073 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 07/01/2010 | US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |